ESC

ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
site-specific bleeding
RWE
ESC
Flag link:
ESC: Merck's Steglatro shows limited promise with heart failure hospitalization data
ESC: Merck's Steglatro shows limited promise with heart failure hospitalization data
Fierce Pharma
Merck
Steglatro
ESC
heart failure
Flag link:
ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one
ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one
Fierce Pharma
Novartis
Entresto
ESC
heart failure
Flag link:
ESC 2020 – Farxiga impresses in chronic kidney disease
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
Flag link:
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
Flag link:
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Flag link:
ESC: AstraZeneca's SGLT2 med Farxiga flips script on competitors with 26% CV risk cut
ESC: AstraZeneca's SGLT2 med Farxiga flips script on competitors with 26% CV risk cut
Fierce Pharma
AstraZeneca
Farxiga
ESC
Flag link:
ESC 2019 – Amarin hopes for guideline boost despite regulatory delay
ESC 2019 – Amarin hopes for guideline boost despite regulatory delay
EP Vantage
Amarin
Vascepa
ESC
European Society of Cardiology
Flag link:
MedCo's PCSK9 challenger steals the show at ESC with winning data
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Flag link:
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
Flag link:
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Europe
ESC
European Society of Cardiology
Flag link:
ESC 2018 preview – A possible boost for Abbott, and balloons go up against stents
ESC 2018 preview – A possible boost for Abbott, and balloons go up against stents
EP Vantage
ESC
devices
Abbott Labs
Flag link: